Biotest Aktiengesellschaft (BIO3) — Cash Flow-to-Debt Ratio
Biotest Aktiengesellschaft (BIO3) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2025, meaning its operating cash flow of €-58.10 Million could theoretically repay 0% of its total liabilities (€906.90 Million) in one year. See free cash flow generation of Biotest Aktiengesellschaft to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biotest Aktiengesellschaft Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Biotest Aktiengesellschaft across 23 annual periods. Also explore Biotest Aktiengesellschaft (BIO3) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Biotest Aktiengesellschaft (2002–2024)
Year-by-year debt coverage analysis for Biotest Aktiengesellschaft. For market capitalisation and broader financial context, see Biotest Aktiengesellschaft (BIO3) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | €60.90 Million | €903.30 Million | ▲ +2377.3% |
| 2023 | 0.00x | €-2.70 Million | €912.00 Million | ▲ +93.9% |
| 2022 | -0.05x | €-40.50 Million | €831.90 Million | ▼ -203.9% |
| 2021 | 0.05x | €33.90 Million | €723.80 Million | ▲ +293.4% |
| 2020 | -0.02x | €-16.70 Million | €689.70 Million | ▲ +54.5% |
| 2019 | -0.05x | €-33.60 Million | €631.50 Million | ▲ +41.8% |
| 2018 | -0.09x | €-50.00 Million | €547.10 Million | ▼ -268.0% |
| 2017 | 0.05x | €34.30 Million | €630.70 Million | ▼ -52.8% |
| 2016 | 0.12x | €65.90 Million | €572.10 Million | ▲ +66.4% |
| 2015 | 0.07x | €38.10 Million | €550.40 Million | ▲ +435.4% |
| 2014 | -0.02x | €-11.40 Million | €552.40 Million | ▼ -22.0% |
| 2013 | -0.02x | €-7.20 Million | €425.80 Million | ▼ -115.2% |
| 2012 | 0.11x | €34.73 Million | €312.91 Million | ▼ -48.4% |
| 2011 | 0.22x | €72.28 Million | €336.09 Million | ▼ -10.3% |
| 2010 | 0.24x | €77.83 Million | €324.73 Million | ▲ +175.1% |
| 2009 | 0.09x | €31.68 Million | €363.59 Million | ▼ -14.4% |
| 2008 | 0.10x | €34.49 Million | €338.67 Million | ▼ -2.6% |
| 2007 | 0.10x | €32.51 Million | €310.94 Million | ▼ -22.6% |
| 2006 | 0.14x | €26.31 Million | €194.69 Million | ▼ -5.5% |
| 2005 | 0.14x | €28.32 Million | €198.12 Million | ▲ +41.5% |
| 2004 | 0.10x | €25.29 Million | €250.31 Million | ▲ +50.9% |
| 2003 | 0.07x | €16.52 Million | €246.69 Million | ▲ +610.6% |
| 2002 | 0.01x | €2.46 Million | €261.20 Million | — |